Towards Healthcare
Latin America Pharmaceutical Market to Promote USD 172.71 Bn by 2034

Latin America Pharmaceutical Market Rising Demand and Strategic Investments

Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for innovative therapies. In Latin America, Brazil dominates the market, driven by strong healthcare infrastructure, government support, and a growing pharmaceutical manufacturing sector.

Content

  • Insight Code: 6296
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The Latin America pharmaceutical market is worth USD 97.84 billion in 2025, and by 2034, it is forecasted to hit USD 172.71 billion, registering a CAGR of 6.52% over the decade.

Brazil is currently leading the Latin America pharmaceutical market share 38% due to its well-established healthcare infrastructure, large patient population, and strong domestic pharmaceutical manufacturing capabilities.

Johnson & Johnson (Janssen), GlaxoSmithKline (GSK), Merck & Co. (MSD), AstraZeneca, EMS (Brazil), Hypera Pharma (Brazil), Eurofarma (Brazil / regional) 

Country-specific approvals are required, often referencing recognized authorities like the US FDA or EU; Brazil ANVISA also uses streamlined processes for faster approvals.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions